9536 Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices 

The agenda will focus on the 

oversight of genetic testing, including 

the role of the private sector in assuring 

the quality and validity of genetic tests; 

the impact of gene patents and licensing 

practices on patient access to genetic 

technologies, including a progress 

report on the Committee’s study; and 

the status of Federal genetic information 

nondiscrimination legislation. The 

Committee will be briefed on the 

Secretary’s Personalized Health Care 

Initiative and the work of the American 

Health Information Community, 

particularly its Personalized Health Care 

Working Group. The Committee’s report 

on the Policy Issues Associated with 

Undertaking a New Large U.S. 

Population Cohort Project on Genes, 

Environment and Disease will be 

released at the meeting. There also will 

be updates on the Committee’s draft 

report on pharmacogenomics and 

several Federal initiatives and activities. 

Time will be provided each day for 

public comments. The Committee 

would welcome hearing from anyone 

wishing to provide public comment on 

any issue related to genetics, health and 

society. Individuals who would like to 

provide public comment should notify 

the SACGHS Executive Secretary, Ms. 

Sarah Carr, by telephone at 301–496–

9838 or e-mail at sc112c@nih.gov. The 

SACGHS office is located at 6705 

Rockledge Drive, Suite 750, Bethesda, 

MD 20892. Anyone planning to attend 

the meeting, who is in need of special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, is also asked to 

contact the Executive Secretary. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

and genomic technologies and, as 

warranted, to provide advice on these 

issues. The draft meeting agenda and 

other information about SACGHS, 

including information about access to 

the Web cast, will be available at the 

following Web site: http:// 

www4.od.nih.gov/oba/sacghs.htm. 

Dated: February 22, 2007. 

Anna Snouffer, 

Acting Director, NIH Office of Federal 

Advisory Committee Policy. 

[FR Doc. 07–973 Filed 3–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health; Designation of a 

Class of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice of a 

decision to designate a class of 

employees at General Atomics in La 

Jolla, California, as an addition to the 

Special Exposure Cohort (SEC) under 

the Energy Employees Occupational 

Illness Compensation Program Act of 

2000. On February 16, 2007, the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

Atomic Weapons Employer (AWE) 

employees who were monitored or should 

have been monitored for exposure to ionizing 

radiation while working at the General 

Atomics facility in La Jolla, California at the 

following locations: Science Laboratories A, 

B, and C (Building 2); Experimental Building 

(Building 9); Maintenance (Building 10); 

Service Building (Building 11); Buildings 21 

and 22; Hot Cell Facility (Building 23); Waste 

Yard (Buildings 25 and 26); Experimental 

Area (Buildings 27 and 27–1); LINAC 

Complex (Building 30); HTGR–TCF (Building 

31); Fusion Building (Building 33); Fusion 

Doublet III (Building 34); SV–A (Building 

37); SV–B (Building 39); and SV–D (no 

building number) for a number of work days 

aggregating at least 250 work days from 

January 1, 1960, through December 31, 1969, 

or in combination with work days within the 

parameters established for one or more other 

classes of employees in the Special Exposure 

Cohort. 

This designation will become 

effective on March 18, 2007, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 513–

533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 

Dated: February 23, 2007. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 07–948 Filed 3–1–07; 8:45 am] 

BILLING CODE 4160–17–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institute for Occupational 

Safety and Health; Designation of a 

Class of Employees for Addition to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Department of Health and 

Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) gives notice of a 

decision to designate a class of 

employees at the Monsanto Chemical 

Company in Dayton, Ohio, as an 

addition to the Special Exposure Cohort 

(SEC) under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. On February 16, 

2007, the Secretary of HHS designated 

the following class of employees as an 

addition to the SEC: 

Atomic Weapons Employer (AWE) 

employees who were monitored or should 

have been monitored for exposure to ionizing 

radiation while working at Monsanto 

Chemical Company Units I, III, or IV in 

Dayton, Ohio, for a number of work days 

aggregating at least 250 work days during the 

period from January 1, 1943, through 

December 31, 1949, or in combination with 

work days within the parameters established 

for one or more other classes of employees 

in the Special Exposure Cohort. 

This designation will become 

effective on March 18, 2007, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

FOR FURTHER INFORMATION CONTACT: 

Larry Elliott, Director, Office of 

Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 513–

533–6800 (this is not a toll-free 

number). Information requests can also 

be submitted by e-mail to 

OCAS@CDC.GOV. 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices 9537 

Dated: February 23, 2007. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 07–947 Filed 3–1–07; 8:45 am] 

BILLING CODE 4160–17–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards Staff, 

Announces the Following Meeting 

Name: ICD–9–CM Coordination and 

Maintenance (C&M) Committee meeting. 

Time and Date: 9 a.m.–5 p.m., March 22–

23, 2007. 

Place: Centers for Medicare and Medicaid 

Services (CMS) Auditorium, 7500 Security 

Boulevard, Baltimore, Maryland. 

Status: Open to the public. 

Purpose: The C&M meeting is a public 

forum for the presentation of proposed 

modifications to the International 

Classification of Diseases, Ninth-Revision, 

Clinical Modification. 

Matters to be Discussed: Tentative agenda 

items include: 

Migraines and other headache syndromes 

Transplant complications 

Hormone therapy for breast cancer 

Penicillin resistant infections 

Central line infections 

Fetal medicine 

Plateau iris syndrome and pingueculitis 

Secondary diabetes mellitus 

Erythema multiforme 

Malignant pleural effusion 

Autoimmune hepatitis 

Addenda (diagnosis) 

Intraoperative electron radiation therapy 

Intraoperative neurophysiologic monitoring 

Thoracoscopic procedures 

Procedures on vena cava 

STARR procedure for males 

Oversewing of the atrial appendage 

Transjugular biopsy of liver 

Total disc replacement 

Recalled devices 

Motion preserving technologies 

Addenda (procedures) 

ICD–10 procedure coding system (PCS 

update) 

Contact Person for Additional Information: 

Amy Blum, Medical Systems Specialist, 

Classifications and Public Health Data 

Standards Staff, NCHS, 3311 Toledo Road, 

Room 2402, Hyattsville, Maryland 20782, email alb8@cdc.gov, telephone 301–458–4106 

(diagnosis), Mady Hue, Health Insurance 

Specialist, Division of Acute Care, CMS, 7500 

Security Blvd., Baltimore, Maryland 21244, 

e-mail marilu.hue@cms.hhs.gov, telephone 

410–786–4510 (procedures). 

Notice: Because of increased security 

requirements, CMS has instituted stringent 

procedures for entrance into the building by 

non-government employees. Persons without 

a government I.D. will need to show an 

official form of picture I.D., (such as a drivers 

license), and sign-in at the security desk 

upon entering the building. 

Those who wish to attend a specific ICD–

9–CM C&M meeting in the CMS auditorium 

must submit their name and organization for 

addition to the meeting visitor list. Those 

wishing to attend the March 22–23, 2007 

meeting must submit their name and 

organization by March 14, 2007 for inclusion 

on the visitor list. This visitor list will be 

maintained at the front desk of the CMS 

building and used by the guards to admit 

visitors to the meeting. Those who attended 

previous ICD–9–CM C&M meetings will no 

longer be automatically added to the visitor 

list. You must request inclusion of your name 

prior to each meeting you attend. 

Register to attend the meeting online at: 

http://www.cms.hhs.gov/apps/events/. 

Notice: This is a public meeting. However, 

because of fire code requirements, should the 

number of attendants meet the capacity of the 

room, the meeting will be closed. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 26, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–3660 Filed 3–1–07; 8:45 am] 

BILLING CODE 4160–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10098 and CMS–

10114] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS), Department of Health 

and Human Services, is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the Agency’s function; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: 1–800–

MEDICARE Beneficiary Satisfaction 

Survey; Use: The Centers for Medicare 

& Medicaid Services will use the survey 

information for performance evaluation 

of the contractor. The information 

gathered will also be used to validate 

the quality of service delivered, and or 

direct the contractor to performance 

improvement; Form Number: CMS–

10098 (OMB#: 0938–0919); Frequency: 

Reporting—Weekly, Monthly and 

Yearly; Affected Public: Individuals or 

households; Number of Respondents: 

18,000; Total Annual Responses: 

18,000; Total Annual Hours: 2,250. 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: National 

Provider Identifier (NPI) Application 

and Update Form and Supporting 

Regulations in 45 CFR 142.408, 45 CFR 

162.406, 45 CFR 162.408; Use: The 

National Provider Identifier (NPI) 

Application and Update Form is used 

by health care providers to apply for 

NPIs and furnish updates to the 

information they supplied on their 

initial applications. The form is also 

used to deactivate their NPIs if 

necessary. The NPI Application/Update 

form has been revised to further assist 

in uniquely identifying health care 

providers and provide additional 

guidance on how to accurately complete 

the form. The form captures additional 

data elements that will assist with 

unique identification. It also includes 

more detailed instructions. Form 

Number: CMS–10114 (OMB#: 0938–

0931); Frequency: Reporting—On 

occasion, one-time; Affected Public: 

Business or other for-profit, Not-forprofit institutions, and Federal 

government; Number of Respondents: 

325,608; Total Annual Responses: 

325,608; Total Annual Hours: 108,560. 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS Web Site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 


pwalker on PROD1PC71 with NOTICES